Shoulder Innovations, Inc. priced its initial public offering at $15.00 a share, offering 5,000,000 shares of common stock, to list on the New York Stock Exchange under the symbol SI. It filed a Form S-1 registration statement for an initial public offering on July 7, 2025. As of November 6, 2026, its final prospectus is on file (Form 424B4, August 1, 2025).
Sell to companies like Shoulder Innovations, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
Shoulder Innovations, Inc. filed a Form S-1 registration statement for an initial public offering on 2025-07-07. It has amended it 3 times. It filed its final prospectus on 2025-08-01, at a public offering price of $15.00 per share. Each fact below is quoted from the filing named with it.
Also on the record for Shoulder Innovations, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 7, 2026 | Stake report, Schedule 13D/A, by Gilde Healthcare Holding B.V. | 10.7% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 17.7% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G/A, by Ball Robert Joseph | 3.6% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by Casey M. Tansey | 13.3% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by LSV Associates II, LLC | 9.3% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G, by cultivate(MD) Holdings, LLC | 6.7% of the class | 5%+ stakes | Source |
| September 8, 2025 | Stake report, Schedule 13G, by FMR LLC | 19% of the class | 5%+ stakes | Source |
| August 8, 2025 | Stake report, Schedule 13G, by Arboretum Ventures VI, L.P. | 5.8% of the class | 5%+ stakes | Source |
| August 5, 2025 | Stake report, Schedule 13D, by Gilde Healthcare Holding B.V. | 11.8% of the class | 5%+ stakes | Source |
| March 18, 2025 | Form D, private offering | $20.11M sold | Form D page | Source |
Check before you invest in Shoulder Innovations, Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Shoulder Innovations, Inc. and the records around it.
The people at Shoulder Innovations, Inc.
- Robert Ball is also named on 1 other Form D filing: Capitan Orthopedics, Inc. (Jan 2026)
Shoulder Innovations, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Form D filing Mar 2025
- Who owns it
Companies that share a holder
- Gilde Healthcare Holding B.V. also filed stake reports on 2 other companies: Mobia Medical, Inc. (May 2026), SpyGlass Pharma, Inc. (Feb 2026)
- U.S. Venture Partners XII, L.P. also filed stake reports on 2 other companies: Mobia Medical, Inc. (Aug 2026), Carlsmed, Inc. (Nov 2025)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Also filing to list on the New York Stock Exchange
IPO filings on the New York Stock Exchange in Q3 2025, newest first.
- StubHub Holdings, Inc. (Sep 2025)
- Via Transportation, Inc. (Sep 2025)
- Klarna Group plc (Sep 2025)
- Circle Internet Group, Inc. (Aug 2025)
- Figma, Inc. (Jul 2025)
Watch Shoulder Innovations, Inc.
Get an email when Shoulder Innovations, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Shoulder Innovations, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Shoulder Innovations, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shoulder Innovations, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
What the filings say
Listing
We have been approved to list our common stock on the New York Stock Exchange under the trading symbol “SI.”From the 424B4 filed 2025-08-01
Shares offered
We are offering 5,000,000 shares of our common stock.From the 424B4 filed 2025-08-01
Offering price
The public offering price is $15.00 per share.From the 424B4 filed 2025-08-01
Use of proceeds
We currently intend to use the net proceeds from this offering (i) to scale up our commercial organization through the hiring of additional sales representatives and expansion of our commercial leadership team, as well as to invest in additional instrument sets, (ii) to fund the research and development of continued general innovation in our implant systems and (iii) for working capital and other general corporate purposes.From the 424B4 filed 2025-08-01
Revenue
We generated net revenue of $31.6 million for the year ended December 31, 2024, compared to net revenue of $19.3 million for the year ended December 31, 2023, representing 64.0% year-over-year growth.From the S-1/A filed 2025-07-25
Net loss or income
We recognized a gross margin of 77.0% and net loss of $15.6 million for the year ended December 31, 2024, compared to a gross margin of 79.2% and net loss of $12.7 million for the year ended December 31, 2023.From the S-1/A filed 2025-07-25
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-07-07 | Registration statement filed | S-1 |
| 2025-07-09 | Registration statement amended | S-1/A |
| 2025-07-24 | Registration statement amended | S-1/A |
| 2025-07-25 | Registration statement amended | S-1/A |
| 2025-08-01 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Shoulder Innovations, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.